{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:06:25Z","timestamp":1784945185986,"version":"3.55.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD033357"],"award-info":[{"award-number":["DP5OD033357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Drs. Stanley and Rosanne Crooke"},{"name":"n-Lorem Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adult polyglucosan body disease (APBD) is a rare, adult-onset neurodegenerative disorder caused by loss-of-function variants in the glycogen branching enzyme (GBE1) gene, essential for glycogen biosynthesis. The second most common pathogenic mutation in APBD (c.2053-3358_2053-3350delinsTGTTTTTTACATGACAGGT) is a deep intronic deletion insertion (indel) variant creating an ectopic splice acceptor site, resulting in a mutant transcript with a pseudoexon encoding an unstable truncated protein. Such mutations can be effectively targeted with splice-modulating antisense oligonucleotides (ASOs) to restore normal splicing. Here, we characterized the indel in-depth using long-read sequencing techniques and discovered several new features of the mutant transcript. The indel sequence varies from the previously identified sequence by a nucleotide, and the usage of the ectopic splice site results in two mutant isoforms, both of which are targets of cellular nonsense-mediated decay. High-throughput screening in patient-derived fibroblasts identified multiple lead candidates that effectively blocked the ectopic splice site and increased the canonical GBE1 transcript and protein. Functional analysis confirmed that treatment with the lead ASOs significantly improved GBE1 enzyme activity in patient cells, validating their therapeutic potential. Taken together, our data demonstrate\u00a0the successful discovery of ASOs that correct mis-splicing, thus offering a promising treatment for a subset of APBD patients.<\/jats:p>","DOI":"10.1093\/nar\/gkaf658","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:16:40Z","timestamp":1752585400000},"source":"Crossref","is-referenced-by-count":6,"title":["Splice-modulating antisense oligonucleotides targeting a pathogenic intronic variant in adult polyglucosan body disease correct mis-splicing and restore enzyme activity in patient cells"],"prefix":"10.1093","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2037-7473","authenticated-orcid":false,"given":"Ria","family":"Thomas","sequence":"first","affiliation":[{"name":"n-Lorem Foundation , Carlsbad , CA 92010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-0560","authenticated-orcid":false,"given":"Emily","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"n-Lorem Foundation , Carlsbad , CA 92010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-721X","authenticated-orcid":false,"given":"Hasan\u00a0O","family":"Akman","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Columbia University Irving Medical Center Department of Neurology, , New\u00a0York , NY 10032 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3099-9738","authenticated-orcid":false,"given":"Sophie\u00a0H R","family":"Storz","sequence":"additional","affiliation":[{"name":"Brotman Baty Institute for Precision Medicine, University of Washington Department of Pediatrics, Department of Laboratory Medicine and Pathology, , Seattle , WA 98195 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-2879","authenticated-orcid":false,"given":"Joy","family":"Goffena","sequence":"additional","affiliation":[{"name":"Brotman Baty Institute for Precision Medicine, University of Washington Department of Pediatrics, Department of Laboratory Medicine and Pathology, , Seattle , WA 98195 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-9432","authenticated-orcid":false,"given":"Julia","family":"Pytte","sequence":"additional","affiliation":[{"name":"n-Lorem Foundation , Carlsbad , CA 92010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-8601","authenticated-orcid":false,"given":"Danny\u00a0E","family":"Miller","sequence":"additional","affiliation":[{"name":"Brotman Baty Institute for Precision Medicine, University of Washington Department of Pediatrics, Department of Laboratory Medicine and Pathology, , Seattle , WA 98195 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-9757","authenticated-orcid":false,"given":"Konstantina","family":"Skourti-Stathaki","sequence":"additional","affiliation":[{"name":"n-Lorem Foundation , Carlsbad , CA 92010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-1520","authenticated-orcid":false,"given":"Stanley\u00a0T","family":"Crooke","sequence":"additional","affiliation":[{"name":"n-Lorem Foundation , Carlsbad , CA 92010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025071612532814900_B1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann Neurol"},{"key":"2025071612532814900_B2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jimd.12325","article-title":"GBE1-related disorders: adult polyglucosan body disease and its neuromuscular phenotypes","volume":"44","author":"Souza","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"2025071612532814900_B3","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1007\/s00415-022-10960-z","article-title":"Characterization of cognitive impairment in adult polyglucosan body disease","volume":"269","author":"Zebhauser","year":"2022","journal-title":"J Neurol"},{"key":"2025071612532814900_B4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/WNO.0000000000002186","article-title":"Neuro-ophthalmic manifestations of adult polyglucosan body disease","volume":"45","author":"Dugue","year":"2025","journal-title":"J Neuroophthalmol"},{"key":"2025071612532814900_B5","first-page":"55","article-title":"Familial dementia due to adult polyglucosan body disease","volume":"16","author":"Bigio","year":"1997","journal-title":"Clin Neuropathol"},{"key":"2025071612532814900_B6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/brain\/103.2.315","article-title":"A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora\u2019s disease and normal ageing","volume":"103","author":"Robitaille","year":"1980","journal-title":"Brain"},{"key":"2025071612532814900_B7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00005072-198807000-00007","article-title":"Adult polyglucosan body disease (APBD)","volume":"47","author":"Gray","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025071612532814900_B8","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1093\/hmg\/ddv385","article-title":"A novel mouse model that recapitulates adult-onset glycogenosis type 4","volume":"24","author":"Orhan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2025071612532814900_B9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting Gys1 with AAV-SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and Lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"2025071612532814900_B10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s13311-022-01218-7","article-title":"AAV-mediated artificial miRNA reduces pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and Lafora disease mouse models","volume":"19","author":"Gumusgoz","year":"2022","journal-title":"Neurotherapeutics"},{"key":"2025071612532814900_B11","doi-asserted-by":"publisher","first-page":"e99694","DOI":"10.1172\/jci.insight.99694","article-title":"Guaiacol as a drug candidate for treating adult polyglucosan body disease","volume":"3","author":"Kakhlon","year":"2018","journal-title":"JCI Insight"},{"key":"2025071612532814900_B12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/hum.2016.099","article-title":"Systemic correction of murine glycogen storage disease type IV by an AAV-mediated gene therapy","volume":"28","author":"Yi","year":"2017","journal-title":"Hum Gene Ther"},{"key":"2025071612532814900_B13","doi-asserted-by":"publisher","first-page":"e14554","DOI":"10.15252\/emmm.202114554","article-title":"Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism","volume":"13","author":"Kakhlon","year":"2021","journal-title":"EMBO Mol Med"},{"key":"2025071612532814900_B14","doi-asserted-by":"publisher","first-page":"26330040241227452","DOI":"10.1177\/26330040241227452","article-title":"A United States-based patient-reported adult polyglucosan body disease registry: initial results","volume":"5","author":"Sparks","year":"2024","journal-title":"Ther Adv Rare Dis"},{"key":"2025071612532814900_B15","first-page":"1993","article-title":"GBE1 Adult Polyglucosan Body Disease","volume-title":"GeneReviews(R)","author":"Akman","year":"2020"},{"key":"2025071612532814900_B16","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s00415-015-7859-4","article-title":"Frequent misdiagnosis of adult polyglucosan body disease","volume":"262","author":"Hellmann","year":"2015","journal-title":"J Neurol"},{"key":"2025071612532814900_B17","doi-asserted-by":"crossref","first-page":"004","DOI":"10.37871\/ajrddt.id17","article-title":"Estimating the prevalence of the adult polyglucosan body disease at the gene level for Ashkenazi Jews in the United States","volume":"3","author":"Schwartz","year":"2020","journal-title":"J Rare Dis Diagn Ther"},{"key":"2025071612532814900_B18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamaneurol.2014.4496","article-title":"Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease","volume":"72","author":"Akman","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025071612532814900_B19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2025071612532814900_B20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1089\/hum.2010.010","article-title":"Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy","volume":"21","author":"Rimessi","year":"2010","journal-title":"Hum Gene Ther"},{"key":"2025071612532814900_B21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/humu.22379","article-title":"In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs","volume":"34","author":"Bl\u00e1zquez","year":"2013","journal-title":"Hum Mutat"},{"key":"2025071612532814900_B22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/hum.2013.052","article-title":"Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy","volume":"24","author":"Rendu","year":"2013","journal-title":"Hum Gene Ther"},{"key":"2025071612532814900_B23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acn3.96","article-title":"A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides","volume":"1","author":"Dominov","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"2025071612532814900_B24","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1093\/nar\/gkv275","article-title":"Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T&gt;C MTRR mutation corrects splicing and restores enzyme activity in patient cells","volume":"43","author":"Palhais","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025071612532814900_B25","first-page":"2552","article-title":"In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery","volume":"25","author":"Garanto","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2025071612532814900_B26","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1038\/mtna.2016.89","article-title":"Antisense oligonucleotide-based splice correction for USH2A-associated retinal degeneration caused by a frequent deep-intronic mutation","volume":"5","author":"Slijkerman","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"2025071612532814900_B27","doi-asserted-by":"publisher","first-page":"e2401781121","DOI":"10.1073\/pnas.2401781121","article-title":"Splice modulation strategy applied to deep intronic variants in COL7A1 causing recessive dystrophic epidermolysis bullosa","volume":"121","author":"Pironon","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025071612532814900_B28","doi-asserted-by":"publisher","first-page":"e124403","DOI":"10.1172\/jci.insight.124403","article-title":"A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies","volume":"4","author":"Bolduc","year":"2019","journal-title":"JCI Insight"},{"key":"2025071612532814900_B29","first-page":"7454","article-title":"Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells","volume":"48","author":"Michaels","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2025071612532814900_B30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025071612532814900_B31","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/jbmr.4647","article-title":"Targeted long-read sequencing identifies a retrotransposon insertion as a cause of altered GNAS exon A\/B methylation in a family with autosomal dominant pseudohypoparathyroidism type 1b (PHP1B)","volume":"37","author":"Miller","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2025071612532814900_B32","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"2025071612532814900_B33","doi-asserted-by":"publisher","first-page":"bbac301","DOI":"10.1093\/bib\/bbac301","article-title":"Clair3-trio: high-performance Nanopore long-read variant calling in family trios with trio-to-trio deep neural networks","volume":"23","author":"Su","year":"2022","journal-title":"Brief Bioinform"},{"key":"2025071612532814900_B34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/bioinformatics\/btac058","article-title":"LongPhase: an ultra-fast chromosome-scale phasing algorithm for small and large variants","volume":"38","author":"Lin","year":"2022","journal-title":"Bioinformatics"},{"key":"2025071612532814900_B35","doi-asserted-by":"crossref","unstructured":"Danecek P, Bonfield JK, Liddle J \u00a0et al. \u00a0Twelve years of SAMtools and BCFtools. Gigascience. 2021; 10:giab00810.1093\/gigascience\/giab008.","DOI":"10.1093\/gigascience\/giab008"},{"key":"2025071612532814900_B36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2025071612532814900_B37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2025071612532814900_B38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025071612532814900_B39","doi-asserted-by":"publisher","first-page":"e1006360","DOI":"10.1371\/journal.pcbi.1006360","article-title":"ggsashimi: sashimi plot revised for browser- and annotation-independent splicing visualization","volume":"14","author":"Garrido-Mart\u00edn","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"2025071612532814900_B40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet"},{"key":"2025071612532814900_B41","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"2025071612532814900_B42","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp","volume":"2","author":"Chen","year":"2023","journal-title":"Imeta"},{"key":"2025071612532814900_B43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41587-022-01565-y","article-title":"Accurate isoform discovery with IsoQuant using long reads","volume":"41","author":"Prjibelski","year":"2023","journal-title":"Nat Biotechnol"},{"key":"2025071612532814900_B44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2025071612532814900_B45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"2025071612532814900_B46","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol"},{"key":"2025071612532814900_B47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/nat.2022.0034","article-title":"Inflammatory non-CpG antisense oligonucleotides are signaling through TLR9 in human burkitt lymphoma B bjab cells","volume":"32","author":"Pollak","year":"2022","journal-title":"Nucleic Acid Ther"},{"key":"2025071612532814900_B48","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"2025071612532814900_B49","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.omtn.2023.08.011","article-title":"Characterization of cooperative PS-oligo activation of human TLR9","volume":"33","author":"Pollak","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"2025071612532814900_B50","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1093\/nar\/gkac618","article-title":"Insights into innate immune activation via PS-ASO-protein-TLR9 interactions","volume":"50","author":"Pollak","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025071612532814900_B51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2350-12-141","article-title":"Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching","volume":"12","author":"Fragall","year":"2011","journal-title":"BMC Med Genet"},{"key":"2025071612532814900_B52","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s44321-024-00063-9","article-title":"Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism","volume":"16","author":"Wu","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2025071612532814900_B53","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1042\/BCJ20170469","article-title":"A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease","volume":"474","author":"Solmesky","year":"2017","journal-title":"Biochem J"},{"key":"2025071612532814900_B54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/biom14080893","article-title":"The autophagic activator GHF-201 can alleviate pathology in a mouse model and in patient fibroblasts of type III glycogenosis","volume":"14","author":"Mishra","year":"2024","journal-title":"Biomolecules"},{"key":"2025071612532814900_B55","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2025071612532814900_B56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"key":"2025071612532814900_B57","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.jbc.2021.100416","article-title":"Antisense technology: a review","volume":"296","author":"Crooke","year":"2021","journal-title":"J Biol Chem"},{"key":"2025071612532814900_B58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41587-021-00945-0","article-title":"A call to arms against ultra-rare diseases","volume":"39","author":"Crooke","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2025071612532814900_B59","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N Engl J Med"},{"key":"2025071612532814900_B60","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"2025071612532814900_B61","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41591-024-03197-y","article-title":"Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder","volume":"30","author":"Ziegler","year":"2024","journal-title":"Nat Med"},{"key":"2025071612532814900_B62","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41591-023-02335-2","article-title":"Personalized antisense oligonucleotides \u2018for free, for life\u2019\u2014the n-Lorem Foundation","volume":"29","author":"Gleeson","year":"2023","journal-title":"Nat Med"},{"key":"2025071612532814900_B63","doi-asserted-by":"publisher","first-page":"26330040241273465","DOI":"10.1177\/26330040241273465","article-title":"Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics","volume":"5","author":"Aartsma-Rus","year":"2024","journal-title":"Ther Adv Rare Dis"},{"key":"2025071612532814900_B64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/nat.2022.0060","article-title":"Consensus guidelines for the design and in vitro preclinical efficacy testing N-of-1 exon skipping antisense oligonucleotides","volume":"33","author":"Aartsma-Rus","year":"2023","journal-title":"Nucleic Acid Ther"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/13\/gkaf658\/63778690\/gkaf658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/13\/gkaf658\/63778690\/gkaf658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:53:37Z","timestamp":1752684817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/doi\/10.1093\/nar\/gkaf658\/8203452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":64,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaf658","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,22]]},"published":{"date-parts":[[2025,7,8]]},"article-number":"gkaf658"}}